Skip to search formSkip to main contentSkip to account menu

ravuconazole

Known as: 3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol, p-(2-((alphaR,betaR)-2,4-Difluoro-beta-hydroxy-alpha-methyl-beta-(1H-1,2,4-triazol-1-ylmethyl)phenethyl)-4-thiazolyl)benzonitrile 
A triazole with antifungal activity. Ravuconazole inhibits 14a demethylase, an enzyme involved in sterol synthesis, resulting in lysis of the fungal… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Some 350 million people in 98 countries are at risk annually for developing cutaneous, mucocutaneous, or visceral leishmaniasis… 
2013
2013
transplantation. He was class I thalassemic by Pesaro classification. He was conditioned with busulfan and cyclophosphamide. He… 
2013
2013
本发明涉及用于制造非对映异构体以及对映异构体富集的三唑化合物艾沙康唑和雷夫康唑的方法,该方法包括在酮和2‑卤化锌丙酸酯之间进行列福马茨基反应,随后进行拆分步骤,优选是用酯酶进行酶法拆分。 
2013
2013
viii Chagas disease, caused by the protozoan pathogen Trypanosoma cruzi, remains a challenging infection due to the… 
2008
2008
1386 © 2008 The Authors JEADV 2008, 22, 1365–1401 Journal compilation © 2008 European Academy of Dermatology and Venereology… 
2004
2004
Objective To evaluate the in vitro activities of ravuconazole and fluconazole against clinical and environmental isolates… 
Review
2002
Review
2002
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2000
2000
Des infections en augmentation : Les infections fongiques systemiques, essentiellement representees par les candidoses mais aussi…